Director/PDMR Shareholding

RNS Number : 7762H
Nanoco Group PLC
03 June 2011
 



 

                                                                                                                        3 June 2011

 

NANOCO GROUP plc

("Nanoco" or the "Company")

 

Director/PDMR Shareholding

In accordance with the terms of the Company's Long Term Incentive plan, the Board has granted the following options in respect of its ordinary shares to certain Directors of the Company and to Andrew Gooda (manufacturing manager). These options, which were granted following the recommendation of the Remuneration Committee and after consulting its advisers, are subject to stringent performance conditions.


Amount paid for grant of option

Number of shares

Exercise price

Michael Edelman

Nil

189,274

79.25p

Nigel Pickett

Nil

138,801

79.25p

Colin White

Nil

138,801

79.25p

Andrew Gooda

Nil

117,539

79.25p

All other terms and conditions of these incentivisation arrangements are in conformity with the Company's existing Long Term Incentive Plan.

Following the options granted above, the Directors' and Andrew Gooda's interests in the total voting rights of the Company are as detailed below:

 

 

 

Total number of share options held

Percentage of issued share capital

 

No. of Ordinary Shares

 

Percentage of issued share capital

 

Michael Edelman

1,983,024

1.0%

9,272,940

4.5%

Nigel Pickett

1,845,051

0.9%

10,451,931

5.1%

Colin White

588,801

0.3%

-

-

Andrew Gooda

417,539

0.2%

-

-

 

 

For further information please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer


Colin White, Chief Financial Officer




Bank of America Merrill Lynch - Corporate Broker

Tel: + 44 (0) 20 7996 2490

Will Smith




Zeus Capital

Tel: +44 (0) 161 831 1512

Alex Clarkson


Nick Cowles




Buchanan Communications

Tel: +44 (0) 20 7466 5000

Mark Court / Christian Goodbody 


 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications including lighting, solar cells and biological imaging. Nanoco's quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass. Nanoco forms strategic partnerships with major end users across a range of applications.

Nanoco was founded in 2001 and is based in Manchester, UK. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.

For further information, please visit www.nanocotechnologies.com.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDKBDPNBKDNAK
UK 100

Latest directors dealings